Literature DB >> 18669643

Selective partial agonism of liver X receptor alpha is related to differential corepressor recruitment.

Caroline A Phelan1, Joseph M Weaver, David J Steger, Shree Joshi, Jeffrey T Maslany, Jon L Collins, William J Zuercher, Timothy M Willson, Max Walker, Michael Jaye, Mitchell A Lazar.   

Abstract

Classically, activated transcription by nuclear receptors (NRs) is due to a ligand-induced switch from corepressor- to coactivator-bound states. However, coactivators and corepressors recognize overlapping surfaces of liganded and unliganded NRs, respectively. Here we show that, at sufficiently high concentration, the NR corepressor (NCoR) influences the activity of the liver X receptor (LXR) even in the presence of a potent full agonist that destabilizes NCoR binding. Partial agonist ligands that less effectively dissociate NCoR from LXR are even more sensitive to NCoR levels, in a target gene-selective manner. Thus, differential recruitment of NCoR is a major determinant of partial agonism and selective LXR modulation of target genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669643      PMCID: PMC2582537          DOI: 10.1210/me.2008-0041

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  33 in total

1.  The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.

Authors:  X Hu; M A Lazar
Journal:  Nature       Date:  1999-11-04       Impact factor: 49.962

2.  A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity.

Authors:  Robert J Schmidt; James V Ficorilli; Youyan Zhang; Kelli S Bramlett; Thomas P Beyer; Kristen Borchert; Michele S Dowless; Keith A Houck; Thomas P Burris; Patrick I Eacho; Guosheng Liang; Li-Wei Guo; William K Wilson; Laura F Michael; Guoqing Cao
Journal:  J Lipid Res       Date:  2006-01-13       Impact factor: 5.922

3.  Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway.

Authors:  J M Lehmann; S A Kliewer; L B Moore; T A Smith-Oliver; B B Oliver; J L Su; S S Sundseth; D A Winegar; D E Blanchard; T A Spencer; T M Willson
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

4.  Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha.

Authors:  T A Spencer; D Li; J S Russel; J L Collins; R K Bledsoe; T G Consler; L B Moore; C M Galardi; D D McKee; J T Moore; M A Watson; D J Parks; M H Lambert; T M Willson
Journal:  J Med Chem       Date:  2001-03-15       Impact factor: 7.446

5.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

6.  Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha).

Authors:  J Y Chiang; R Kimmel; D Stroup
Journal:  Gene       Date:  2001-01-10       Impact factor: 3.688

7.  Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.

Authors:  Elaine M Quinet; Dawn A Savio; Anita R Halpern; Liang Chen; Christopher P Miller; Ponnal Nambi
Journal:  J Lipid Res       Date:  2004-08-01       Impact factor: 5.922

8.  Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator.

Authors:  Bowman Miao; Susan Zondlo; Sandy Gibbs; Debra Cromley; Vinayak P Hosagrahara; Todd G Kirchgessner; Jeffrey Billheimer; Ranjan Mukherjee
Journal:  J Lipid Res       Date:  2004-05-16       Impact factor: 5.922

9.  Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles.

Authors:  Aldo Grefhorst; Baukje M Elzinga; Peter J Voshol; Torsten Plösch; Tineke Kok; Vincent W Bloks; Fjodor H van der Sluijs; Louis M Havekes; Johannes A Romijn; Henkjan J Verkade; Folkert Kuipers
Journal:  J Biol Chem       Date:  2002-07-03       Impact factor: 5.157

10.  X-ray crystal structure of the liver X receptor beta ligand binding domain: regulation by a histidine-tryptophan switch.

Authors:  Shawn Williams; Randy K Bledsoe; Jon L Collins; Sharon Boggs; Millard H Lambert; Ann B Miller; John Moore; David D McKee; Linda Moore; Jason Nichols; Derek Parks; Mike Watson; Bruce Wisely; Timothy M Willson
Journal:  J Biol Chem       Date:  2003-05-07       Impact factor: 5.157

View more
  12 in total

1.  Structure, energetics, and dynamics of binding coactivator peptide to the human retinoid X receptor α ligand binding domain complex with 9-cis-retinoic acid.

Authors:  Gang Xia; LeeAnn J Boerma; Bryan D Cox; Cheng Qiu; Sebyung Kang; Craig D Smith; Matthew B Renfrow; Donald D Muccio
Journal:  Biochemistry       Date:  2010-12-08       Impact factor: 3.162

2.  Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis.

Authors:  Colin A Flaveny; Kristine Griffett; Bahaa El-Dien M El-Gendy; Melissa Kazantzis; Monideepa Sengupta; Antonio L Amelio; Arindam Chatterjee; John Walker; Laura A Solt; Theodore M Kamenecka; Thomas P Burris
Journal:  Cancer Cell       Date:  2015-06-25       Impact factor: 31.743

3.  Inhibition of Pancreatic Cancer Cell-Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol.

Authors:  Feng Wang; Frank Stappenbeck; William Matsui; Farhad Parhami
Journal:  J Cell Biochem       Date:  2016-09-21       Impact factor: 4.429

4.  A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice.

Authors:  Dacheng Peng; Richard A Hiipakka; Jing-Tian Xie; Qing Dai; John M Kokontis; Catherine A Reardon; Godfrey S Getz; Shutsung Liao
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 5.  PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Nucl Recept Signal       Date:  2010-04-16

6.  In silico identification of small molecules as novel LXR agonists for the treatment of cardiovascular disease and cancer.

Authors:  Xin Wang; Kaimin Lu; Hao Luo; Danfeng Liang; Xin Long; Yuan Yuan; Chuanfang Wu; Jinku Bao
Journal:  J Mol Model       Date:  2018-02-15       Impact factor: 1.810

7.  The influence of ligand-activated LXR on primary human trophoblasts.

Authors:  J C Larkin; S B Sears; Y Sadovsky
Journal:  Placenta       Date:  2014-09-10       Impact factor: 3.481

Review 8.  Liver X receptors and fat cell metabolism.

Authors:  J Laurencikiene; M Rydén
Journal:  Int J Obes (Lond)       Date:  2012-02-28       Impact factor: 5.095

9.  Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism.

Authors:  Nancy Nader; Sinnie Sin Man Ng; Yonghong Wang; Brent S Abel; George P Chrousos; Tomoshige Kino
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

10.  Loss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cells.

Authors:  Rohit Anthony Sinha; Brijesh K Singh; Jin Zhou; Sherwin Xie; Benjamin L Farah; Ronny Lesmana; Kenji Ohba; Madhulika Tripathi; Sujoy Ghosh; Anthony N Hollenberg; Paul M Yen
Journal:  Autophagy       Date:  2016-11-15       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.